ABIM Rheumatology study materials
ABIM Rheumatology study resources

Differentiating Flare From Infection in a Febrile Patient With Vasculitis

ABIM Rheumatology · Put your knowledge to work in context.

All case studies

Differentiating Flare From Infection in a Febrile Patient With Vasculitis

A 71-year-old man with recently diagnosed ANCA-associated vasculitis (MPO-positive, renal involvement) completed induction with cyclophosphamide and high-dose glucocorticoids 6 weeks ago and is now on rituximab maintenance plus prednisone 10 mg daily. He presents with 3 days of fever to 38.7°C, new dry cough, and mild dyspnea. He has no hemoptysis. Exam: HR 104, RR 22, SpO2 91% on room air, scattered crackles. Labs: WBC 9,800 (neutrophils 82%, lymphocytes 400/µL), CRP 90 mg/L, creatinine stable at 1.4 mg/dL (baseline 1.3), urinalysis with 5–10 RBC/hpf and no casts, rising MPO titer compared with 3 months ago. Chest radiograph shows a new right lower lobe infiltrate.

1. How do you weigh vasculitis flare versus infection here, and what is your initial approach?

Read the worked answer

Infection is the default assumption in an immunosuppressed patient with fever and a new infiltrate; do not attribute fever to vasculitis until infection is excluded. Supporting infection: fever, productive-sounding cough, focal infiltrate, lymphopenia (400/µL), recent cyclophosphamide and high-dose steroids. Supporting flare: rising MPO titer and mild hematuria - but ANCA titers do not reliably track disease activity and should not drive treatment decisions, and 5–10 RBC/hpf without casts or rising creatinine is not convincing active glomerulonephritis. Initial approach: obtain blood cultures, sputum/Gram stain and cultures, urine culture, and consider bronchoalveolar lavage if diagnosis is unclear or the patient is worsening; start empiric broad-spectrum antibiotics covering typical and atypical organisms (and consider opportunistic pathogens such as Pneumocystis given steroids). Hold or minimize further immunosuppression escalation until infection is addressed. Avoid empiric pulse steroids for a presumed flare without evidence.

2. Cultures are negative, but he worsens over 48 hours with increasing oxygen requirement and the infiltrate enlarges. What is your next diagnostic and therapeutic step?

Read the worked answer

Worsening despite antibiotics with negative cultures raises the possibility of diffuse alveolar hemorrhage from active vasculitis or an opportunistic infection not captured by routine cultures (e.g., Pneumocystis, fungal, viral). Next steps: urgent bronchoscopy with BAL - look for bloody returns/siderophages suggesting alveolar hemorrhage, and send fluid for Pneumocystis PCR, fungal stains/cultures, viral PCR (including CMV, influenza, SARS-CoV-2), and bacterial/fungal cultures. Obtain HRCT. If BAL confirms alveolar hemorrhage and infection is adequately excluded, treat as pulmonary flare with high-dose glucocorticoids and consider escalation (e.g., additional rituximab or cyclophosphamide) in consultation with rheumatology. If an opportunistic pathogen is found, treat it and reduce immunosuppression. Continue supportive care; reassess renal function and urinalysis serially.